Diabeloop’s DBLG2 receives FDA and CE clearance for automated insulin delivery without meal input
While a lack of meal announcements can lead to lower glycaemic control, it reduces the mental burden for those with type 1 diabetes
Read More
Feb 19, 2026 | News, Regulatory
While a lack of meal announcements can lead to lower glycaemic control, it reduces the mental burden for those with type 1 diabetes
Read MoreThe Singapore Life Sciences Trade Accelerator six-month pilot programme aims to increase export opportunities
Read MoreFeb 17, 2026 | News, Regulatory
TK2d is an extremely rare disease characterised by severe and progressive muscle weakness
Read MoreThe RSV virus is highly contagious and can cause serious respiratory illness for infants
Read MoreThere are currently no approved treatments specifically indicated for LS in the US or Europe
Read MoreCagriSema improved weight loss and blood glucose control compared to semaglutide alone across all tested doses
Read MoreFeb 9, 2026 | News, Healthcare
The Awards were sponsored by Inizio, Chase, druid and Robotics AI
Read MoreThere are currently no approved treatments for the neurological symptoms of this disease
Read MoreFeb 6, 2026 | News, Regulatory
Approximately 70% of metastatic triple-negative breast cancer patients are ineligible for immunotherapy, creating an unmet medical need
Read MoreThe disease affects around 1% of the population in most studied countries
Read MoreOver 50 million people across the US live with acne, a condition with no cure that often requires chronic treatment
Read MoreFeb 4, 2026 | News, Regulatory
Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually
Read More
